跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ORGOVYX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ORGOVYX
Authorized
STANDARD
ORGOVYX
Sumitomo Pharma Switzerland GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ede679d918b480d3
Company
Sumitomo Pharma Switzerland GmbH
Type
Standard
Approval Details
Approval Id
ede679d918b480d3
Drug Approval Canada Name
ORGOVYX
Product Name
ORGOVYX
Status
Marketed
Status Date
2023-12-06
Original Market Date
2023-12-06
Din
02542137
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:18.04
Atc Original
L02BX04 RELUGOLIX
Atc Name
l 02 bx 04
Aig Number
0165101001
Company Name
Sumitomo Pharma Switzerland GmbH
Company Address
Aeschengraben 27, Basel, --, Switzerland, 4051
Company Detail Path
/organization/sumitomo-pharma-switzerland-gmbh
Company Information
Pharmaceutical Company Name
Sumitomo Pharma Switzerland GmbH
Country Name
Switzerland
Province Name
Basel-Stadt
City Name
basel,basel-stadt,country_ch
Address
Aeschengraben 27
Active Ingredients
RELUGOLIX
120 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ede679d918b480d3
Type
Standard
Back to Health Canada Approvals